Long Grove Pharmaceuticals is a generics manufacturer providing complex generics to the U.S. market. In-house R&D developments include differentiated generics designed to ease operational burdens in healthcare, supported by parent company Capstone Development Services. New and incremental supplies are released through partnerships with global manufacturers, primarily in Europe and North America. Long Grove’s leadership team brings decades of industry experience with a commitment to product quality and transparency.

• Long Grove Pharmaceuticals
  For more information, visit pppmag.com/info

Visit booth #619 at the ASHP Summer Meeting